News

COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
Williams left the world of tennis behind back in 2022, when she played the final match of her career in the US Open, but she ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...
Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments ...
Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...
Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...
Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...